The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor contains an immunoreceptor tyrosine-based inhibitory motif that activates Shp2

Journal of Virology

Volumn 85, Issue 2, 2011, Pages 1140-1144

  Philpott, Nicola ^a   Bakken, Thomas ^a   Pennell, Christopher ^a   Chen, Liwei ^c   Wu, Jie ^c   Cannon, Mark ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ARTICLE; BIOTINYLATION; CELL STRAIN HEK293; ENZYME ACTIVATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNORECEPTOR TYROSINE BASED INHIBITORY MOTIF; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

AMINO ACID MOTIFS; CELL LINE; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RECEPTORS, CHEMOKINE; SURFACE PLASMON RESONANCE;

HUMAN HERPESVIRUS 8;

EID: 78650639889     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01362-10     Document Type: Article

References (26)

1. Armbruster, B. N., and B. L. Roth. 2005. Mining the receptorome. J. Biol. Chem. 280:5129-5132.
2. Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350.
3. Bakken, T., M. He, and M. L. Cannon. 2010. The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells. Virology 397:379-388.
4. Billadeau, D. D., and P. J. Leibson. 2002. ITAMs versus ITIMs: striking a balance during cell regulation. J. Clin. Invest. 109:161-168.
5. Burger, M., J. A. Burger, R. C. Hoch, Z. Oades, H. Takamori, and I. U. Schraufstatter. 1999. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J. Immunol. 163:2017-2022.
6. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77-85.
7. Cesarman, E., R. G. Nador, F. Bai, R. A. Bohenzky, J. J. Russo, P. S. Moore, Y. Chang, and D. M. Knowles. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-8223.
8. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
9. Duchene, J., J. P. Schanstra, C. Pecher, A. Pizard, C. Susini, J. P. Esteve, J. L. Bascands, and J. P. Girolami. 2002. A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J. Biol. Chem. 277:40375-40383.
10. Hopkins, A. L., and C. R. Groom. 2002. The druggable genome. Nat. Rev. Drug Discov. 1:727-730.
11. Imhof, D., A. S. Wavreille, A. May, M. Zacharias, S. Tridandapani, and D. Pei. 2006. Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pYα3 position. J. Biol. Chem. 281:20271-20282.
12. Jensen, K. K., D. J. Manfra, M. G. Grisotto, A. P. Martin, G. Vassileva, K. Kelley, T. W. Schwartz, and S. A. Lira. 2005. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J. Immunol. 174:3686-3694.
13. Mannell, H., N. Hellwiga, T. Gloea, C. Plankc, H. Sohnb, L. Groessera, B. Walzoga, U. Pohla, and F. Krötza. 2008. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J. Vasc. Res. 45:153-163.
14. Montaner, S., A. Sodhi, A. Molinolo, T. H. Bugge, E. T. Sawai, Y. He, Y. Li, P. E. Ray, and J. S. Gutkind. 2003. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3:23-36.
15. Navratilova, I., J. Sodroski, and D. G. Myszka. 2005. Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal. Biochem. 339:271-281.
16. Neel, B. G., H. Gu, and L. Pao. 2003. The 'Shp'ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284-293.
17. Olsen, S. J., Y. Chang, P. S. Moore, R. J. Biggar, and M. Melbye. 1998. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12: 1921-1925.
18. Poole, A. W., and M. L. Jones. 2005. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell. Signal. 17:1323-1332.
19. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290:84-89.
20. Ribas, C., P. Penela, C. Murga, A. Salcedo, C. Garcia-Hoz, M. Jurado-Pueyo, I. Aymerich, and F. Mayor, Jr. 2007. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim. Biophys. Acta 1768:913-922.
21. Sweeney, M. C., A. S. Wavreille, J. Park, J. P. Butchar, S. Tridandapani, and D. Pei. 2005. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains. Biochemistry 44:14932-14947.
22. Vatinel, S., A. Ferrand, F. Lopez, A. Kowalski-Chauvel, J. P. Esteve, D. Fourmy, M. Dufresne, and C. Seva. 2006. An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway. Biochim. Biophys. Acta 1763:1098-1107.
23. Violin, J. D., and R. J. Lefkowitz. 2007. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28:416-422.
24. Voisin, T., A. El Firar, C. Rouyer-Fessard, V. Gratio, and M. Laburthe. 2008. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism. FASEB J. 22:1993-2002.
25. Wettschureck, N., and S. Offermanns. 2005. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85:1159-1204.
26. Whitby, D., M. R. Howard, M. Tenant-Flowers, N. S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. E. Suggett, D. M. Aldam, and A. S. Denton. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346: 799-802.